Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Prostate cancer researchers publishing in the Cancer Research journal argue for more watchful waiting to manage the disease, rather than moving straight to aggressive treatment or surgery.
Kathryn Penney ScD, instructor in medicine at the Harvard Medical School, added:
"Choosing active surveillance could prevent this decline in quality of life."
The research paper analyzes data from two sets of research - one study with 420 physicians recruited to it, and the other involving 787 health professionals. All had been treated with surgery following diagnosis made between the years 1982 and 2004.
The findings from these studies were divided up according to when the men received their disease diagnosis and treatment.
Correlations between the participants' grade of cancer disease (Gleason score) were drawn against the increasing use of PSA screening by doctors to help identify prostate cancer, which has risen "from 42% in 1994 to 81% in 2000."
The PSA test to detect prostate cancer is a means of screening that gives doctors clues as to whether a man has the disease.
The American Cancer Society (ACS) says most healthy men have levels of PSA (prostate-specific antigen) in their blood of under 4 nanograms per milliliter (ng/mL) and that the diagnostic test indicates a higher chance of prostate cancer the more the result rises above this level.
The PSA level is not completely reliable though - it does not always suggest cancer and does not necessarily show level of malignancy. The oncology experts for ACS list numerous other factors that can influence levels of prostate-specific antigen, including, among other possibilities:
Dr. Kathryn Penney, also associate epidemiologist at Brigham and Women's Hospital in Boston, MA, said:
"Over time, because of PSA screening, men have been more likely to be diagnosed with prostate cancer at an earlier stage, before the disease has had an opportunity to grow and spread."
The analysis by the researchers was designed to find out if the prostate screening test had succeeded in bringing about a reduction in severity of cancers.
But Dr. Kathryn Penney, said of the results:
"We were surprised by just how constant the incidence of high-grade disease has been over time."
"If Gleason grade also progressed over time, we would expect a similar decrease in high Gleason grade disease over time," Dr. Penney continued, adding:
"Men with low-grade disease at diagnosis should seriously consider talking with their doctors about active surveillance."
Written by Markus MacGill
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
Gleason grade progression is uncommon, Kathryn Penney, Meir Stampfer, Jaquelyn Jahn and others, Cancer Res: 73; 5163. Published August 15, 2013.
Visit our Prostate / Prostate Cancer category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
MacGill, Markus. "Research 'backs watchful waiting' in prostate cancer." Medical News Today. MediLexicon, Intl., 16 Aug. 2013. Web.
4 Dec. 2013. <http://www.medicalnewstoday.com/articles/264897>
MacGill, M. (2013, August 16). "Research 'backs watchful waiting' in prostate cancer." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/264897.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.